Mutations in the Cu/Zn‐binding superoxide dismutase (SOD1) gene were the first to be associated with ALS, accounting for around 20% of fALS patients (Rosen et al., 1993; Zou et al., 2017). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.